Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3430-10-2

Post Buying Request

3430-10-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3430-10-2 Usage

Chemical Properties

Off-white Cryst

Check Digit Verification of cas no

The CAS Registry Mumber 3430-10-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,4,3 and 0 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 3430-10:
(6*3)+(5*4)+(4*3)+(3*0)+(2*1)+(1*0)=52
52 % 10 = 2
So 3430-10-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2/c1-5-6(7)3-2-4-8-5/h2-4H,7H2,1H3

3430-10-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H27540)  3-Amino-2-methylpyridine, 97%   

  • 3430-10-2

  • 250mg

  • 594.0CNY

  • Detail
  • Alfa Aesar

  • (H27540)  3-Amino-2-methylpyridine, 97%   

  • 3430-10-2

  • 1g

  • 1499.0CNY

  • Detail
  • Aldrich

  • (662690)  3-Amino-2-methylpyridine  97%

  • 3430-10-2

  • 662690-250MG

  • 780.39CNY

  • Detail
  • Aldrich

  • (662690)  3-Amino-2-methylpyridine  97%

  • 3430-10-2

  • 662690-1G

  • 2,125.89CNY

  • Detail

3430-10-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-methylpyridin-3-amine

1.2 Other means of identification

Product number -
Other names 3-Pyridinamine, 2-methyl-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3430-10-2 SDS

3430-10-2Synthetic route

2,2-dimethyl-3-(2-methylpyrid-3-yl)-4-oxo-4H-1,3-benzoxazine
76809-24-0

2,2-dimethyl-3-(2-methylpyrid-3-yl)-4-oxo-4H-1,3-benzoxazine

A

2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

B

salicylic acid
69-72-7

salicylic acid

Conditions
ConditionsYield
With hydrogenchloride for 3h; Heating;A 93%
B n/a
2-methyl-3-nitropyridine
18699-87-1

2-methyl-3-nitropyridine

2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

Conditions
ConditionsYield
With iron; acetic acid for 2h; Heating;90%
With hydrogen; triethylamine; palladium 10% on activated carbon In methanol at 20℃; under 760.051 Torr; for 6h;
3-aminopyridine-2-acetic acid
80352-63-2

3-aminopyridine-2-acetic acid

2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

Conditions
ConditionsYield
In ethanol for 5h; Heating;86%
6-chloro-4-methyl-3-nitropyridine
22280-60-0

6-chloro-4-methyl-3-nitropyridine

2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

Conditions
ConditionsYield
With palladium on carbon; hydrogen66%
With methanol; Lindlar's catalyst Hydrogenation;
With methanol; palladium on activated charcoal Hydrogenation;
With sulfuric acid; zinc
2-methyl-3-pyridyl tosylate
1260000-13-2

2-methyl-3-pyridyl tosylate

2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

Conditions
ConditionsYield
Stage #1: 2-methyl-3-pyridyl tosylate With [(k2-P,N-di(1-adamantyl)-2-morpholinophenylphosphine)Pd(Ph)Cl]; sodium t-butanolate In 1,4-dioxane Inert atmosphere; Glovebox;
Stage #2: With ammonia In 1,4-dioxane at 24℃; Inert atmosphere; Glovebox;
46%
2-chloro-3-aminopyridine
6298-19-7

2-chloro-3-aminopyridine

dihydroxy-methyl-borane
13061-96-6

dihydroxy-methyl-borane

2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

Conditions
ConditionsYield
With potassium carbonate; tetrakis(triphenylphosphine) palladium(0) In 1,4-dioxane for 120h; Suzuki reaction; Heating;35%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

2-(4,6-dichloropyrimidin-5-yl)acetaldehyde
16019-33-3

2-(4,6-dichloropyrimidin-5-yl)acetaldehyde

N-[2-(4,6-dichloro-5-pyrimidinyl)ethyl]-2-methyl-3-pyridinamine
1001398-59-9

N-[2-(4,6-dichloro-5-pyrimidinyl)ethyl]-2-methyl-3-pyridinamine

Conditions
ConditionsYield
Stage #1: 2-methyl-3-pyridinamine With trifluoroacetic acid at -15℃; for 0.5h;
Stage #2: With sodium tris(acetoxy)borohydride for 0.5h;
Stage #3: 2-(4,6-dichloropyrimidin-5-yl)acetaldehyde With water; sodium hydrogencarbonate more than 3 stages;
100%
With sodium cyanoborohydride; acetic acid In methanol at -15 - 20℃; for 19h;
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

(7aSR,11aSR)-9-oxo-11a-(2,2,2-trifluoro-ethyl)-6,7,7a,8,9,10,11,11a-octahydro-5H-dibenzo[a,c]cycloheptene-3-carboxylic acid

(7aSR,11aSR)-9-oxo-11a-(2,2,2-trifluoro-ethyl)-6,7,7a,8,9,10,11,11a-octahydro-5H-dibenzo[a,c]cycloheptene-3-carboxylic acid

(7aSR,11aSR)-9-oxo-11a-(2,2,2-trifluoro-ethyl)-6,7,7a,8,9,10,11,11a-octahydro-5H-dibenzo[a,c]cycloheptene-3-carboxylic acid (2-methyl-pyridin-3-yl)-amide

(7aSR,11aSR)-9-oxo-11a-(2,2,2-trifluoro-ethyl)-6,7,7a,8,9,10,11,11a-octahydro-5H-dibenzo[a,c]cycloheptene-3-carboxylic acid (2-methyl-pyridin-3-yl)-amide

Conditions
ConditionsYield
Stage #1: (7aSR,11aSR)-9-oxo-11a-(2,2,2-trifluoro-ethyl)-6,7,7a,8,9,10,11,11a-octahydro-5H-dibenzo[a,c]cycloheptene-3-carboxylic acid With N-ethyl-N,N-diisopropylamine; fluoro-N,N,N′,N′-bis(tetramethylene)formamidinium hexafluorophosphate In tetrahydrofuran for 0.333333h;
Stage #2: 2-methyl-3-pyridinamine In tetrahydrofuran at 20 - 60℃; for 77h;
100%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

(7aSR,11aRS)-methyl 11a-ethyl-7,7a,8,10,11,11a-hexahydro-6H-spiro[dibenzo[b,d]oxepine-9,2'-[1.3]dioxolane]-3-carboxylate

(7aSR,11aRS)-methyl 11a-ethyl-7,7a,8,10,11,11a-hexahydro-6H-spiro[dibenzo[b,d]oxepine-9,2'-[1.3]dioxolane]-3-carboxylate

(7aSR,11aRS)-11a-ethyl-N-(2-methylpyridin-3-yl)-7,7a,8,10,11,11a-hexahydro-6H-spiro[dibenzo[b,d]oxepine-9,2'-[1.3]dioxolane]-3-carboxamide

(7aSR,11aRS)-11a-ethyl-N-(2-methylpyridin-3-yl)-7,7a,8,10,11,11a-hexahydro-6H-spiro[dibenzo[b,d]oxepine-9,2'-[1.3]dioxolane]-3-carboxamide

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran; toluene at 0℃; for 0.25h;100%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

C21H26O4

C21H26O4

C26H30N2O3

C26H30N2O3

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran; toluene at 20℃; for 0.0833333h;100%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

7-chloro-2-(4-hydroxyphenyl)-pyrido[3,2-d]pyrimidine
1345955-99-8

7-chloro-2-(4-hydroxyphenyl)-pyrido[3,2-d]pyrimidine

2-(4-hydroxyphenyl)-7-((2-methyl)-pyridin-3-ylamino)-pyrido[3,2-d]pyrimidine
1345956-37-7

2-(4-hydroxyphenyl)-7-((2-methyl)-pyridin-3-ylamino)-pyrido[3,2-d]pyrimidine

Conditions
ConditionsYield
With palladium diacetate; potassium carbonate; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene In 1,4-dioxane at 140℃; for 1h; Buchwald-Hartwig Coupling; Microwave irradiation;97%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

(4a'S,10a'R)-methyl 4a'-benzyl-3',4',4a',10a'-tetrahydro-1'H-spiro[[1,3]dioxolane-2,2'-phenanthrene]-7'-carboxylate
1400926-96-6

(4a'S,10a'R)-methyl 4a'-benzyl-3',4',4a',10a'-tetrahydro-1'H-spiro[[1,3]dioxolane-2,2'-phenanthrene]-7'-carboxylate

(4a'S,10a'R)-4a'-benzyl-N-(2-methylpyridin-3-yl)-3',4',4a',10a'-tetrahydro-1'H-spiro[[1,3]dioxolane-2,2'-phenanthrene]-7'-carboxamide
1400926-97-7

(4a'S,10a'R)-4a'-benzyl-N-(2-methylpyridin-3-yl)-3',4',4a',10a'-tetrahydro-1'H-spiro[[1,3]dioxolane-2,2'-phenanthrene]-7'-carboxamide

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran; toluene at 0 - 20℃; for 1.5h; Inert atmosphere;95%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

(4bS,7R,8aS)-methyl 4b-benzyl-10-methyl-7-(triethylsilyloxy)-7-(trifluoromethyl)-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate
1400927-16-3

(4bS,7R,8aS)-methyl 4b-benzyl-10-methyl-7-(triethylsilyloxy)-7-(trifluoromethyl)-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate

(4bS,7R,8aS)-4b-benzyl-10-methyl-N-(2-methylpyridin-3-yl)-7-(triethylsilyloxy)-7-(trifluoromethyl)-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxamide
1400927-17-4

(4bS,7R,8aS)-4b-benzyl-10-methyl-N-(2-methylpyridin-3-yl)-7-(triethylsilyloxy)-7-(trifluoromethyl)-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxamide

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran; toluene at 0℃; for 1h; Inert atmosphere;92%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

tert-butyl N-(2-methylpyridin-3-yl)carbamate
1219095-87-0

tert-butyl N-(2-methylpyridin-3-yl)carbamate

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 336h;90%
In hexane; ethyl acetate at 60℃;46%
With lithium hexamethyldisilazane In tetrahydrofuran at 20℃; for 16h;
In tetrahydrofuran at 20℃; for 24h; Inert atmosphere;
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

(4bS,8aS)-methyl 4b-benzyl-7-hydroxy-7-(trifluoromethyl)-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxylate
1400926-33-1

(4bS,8aS)-methyl 4b-benzyl-7-hydroxy-7-(trifluoromethyl)-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxylate

(4bS,8aS)-4b-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxamide
1400926-34-2

(4bS,8aS)-4b-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxamide

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran; toluene at 20℃; for 2h;90%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

(4bR,7R,8aR)-4b-benzyl-7-hydroxy-6-oxo-7-phenyl-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxylic acid
1206877-03-3

(4bR,7R,8aR)-4b-benzyl-7-hydroxy-6-oxo-7-phenyl-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxylic acid

(4bR,7R,8aR)-4b-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-6-oxo-7-phenyl-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxamide
1206877-04-4

(4bR,7R,8aR)-4b-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-6-oxo-7-phenyl-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxamide

Conditions
ConditionsYield
With 1-methyl-1H-imidazole; 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide In ethyl acetate; acetonitrile at 25℃;89%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

3-chloro-2-methylpyridine
72093-03-9

3-chloro-2-methylpyridine

Conditions
ConditionsYield
With hydrogenchloride; nitric acid; trichlorophosphate In water at 20 - 25℃;89%
2-Amino-6-methylpyridine
1824-81-3

2-Amino-6-methylpyridine

2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

2,6-pyridine dicarbonyl dichloride

2,6-pyridine dicarbonyl dichloride

pyridine-2,6-dicarboxylic acid diamide
4663-97-2

pyridine-2,6-dicarboxylic acid diamide

Conditions
ConditionsYield
With triethylamine In dichloromethane88%
With triethylamine In dichloromethane88%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

4'-chloro-2-phenylacetophenone
1889-71-0

4'-chloro-2-phenylacetophenone

1-(4-((2-methylpyridin-3-yl)amino)phenyl)-2-phenylethanone
1501945-32-9

1-(4-((2-methylpyridin-3-yl)amino)phenyl)-2-phenylethanone

Conditions
ConditionsYield
With 1,1'-bis-(diphenylphosphino)ferrocene; potassium phosphate; cis-[1,1'-bis(diphenylphosphino)ferrocene](2-methylphenyl)nickel(II) chloride; acetonitrile In tert-butyl alcohol at 110℃; for 16h; Inert atmosphere; Molecular sieve;87%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

rac-methyl (4S,7R)-7-((((tert-butyldimethylsilyl)oxy)methyl)-1-methyl-3-(pyridin-2-yl)-4,6,7,8-tetrahydro-1H-pyrazolo[3,4-e][1,4]thiazepine-4-yl)-3-methylbenzoate

rac-methyl (4S,7R)-7-((((tert-butyldimethylsilyl)oxy)methyl)-1-methyl-3-(pyridin-2-yl)-4,6,7,8-tetrahydro-1H-pyrazolo[3,4-e][1,4]thiazepine-4-yl)-3-methylbenzoate

rac-4-((4S,7R)-(7-((tert-butyldimethylsilyl)oxy)methyl)-1-methyl-3-(pyridin-2-yl)-4,6,7,8-tetrahydro-1H-pyrazolo[3,4-e][1,4]thiazepin-4-yl)-3-methyl-N-(2-methylpyridin-3-yl)benzamide

rac-4-((4S,7R)-(7-((tert-butyldimethylsilyl)oxy)methyl)-1-methyl-3-(pyridin-2-yl)-4,6,7,8-tetrahydro-1H-pyrazolo[3,4-e][1,4]thiazepin-4-yl)-3-methyl-N-(2-methylpyridin-3-yl)benzamide

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran; hexane at 0 - 20℃; for 2h; Cooling;85%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

(4bS,7R,8aS)-methyl 4b-benzyl-7-hydroxy-7-(trifluoromethyl)-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate
1400927-12-9

(4bS,7R,8aS)-methyl 4b-benzyl-7-hydroxy-7-(trifluoromethyl)-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate

(4βS,7R,8αS)-4β-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4β,5,6,7,8,8α-hexahydrophenanthrene-2-carboxamide
1044589-16-3

(4βS,7R,8αS)-4β-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4β,5,6,7,8,8α-hexahydrophenanthrene-2-carboxamide

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran; toluene at 0 - 20℃; for 1.5h;83%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

(4bS,7R,8aR)-methyl 4b-benzyl-7-ethyl-7-hydroxy-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate
1400927-02-7

(4bS,7R,8aR)-methyl 4b-benzyl-7-ethyl-7-hydroxy-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate

(4bS,7R,8aR)-4b-benzyl-7-ethyl-7-hydroxy-N-(2-methylpyridin-3-yl)-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxamide
1400927-03-8

(4bS,7R,8aR)-4b-benzyl-7-ethyl-7-hydroxy-N-(2-methylpyridin-3-yl)-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxamide

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran; toluene at 0 - 20℃; for 0.833333h; Inert atmosphere;82%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

(7aSR,9SR,11aRS)-11a-ethyl-9-hydroxy-9-(3,3,3-trifluoro-propyl)-6,7,7a,8,9,10,11,11a-octahydro-5H-dibenzo[a,c]cycloheptene-3-carboxylic acid methyl ester

(7aSR,9SR,11aRS)-11a-ethyl-9-hydroxy-9-(3,3,3-trifluoro-propyl)-6,7,7a,8,9,10,11,11a-octahydro-5H-dibenzo[a,c]cycloheptene-3-carboxylic acid methyl ester

(7aSR,9SR,11aRS)-11a-ethyl-9-hydroxy-9-(3,3,3-trifluoro-propyl)-6,7,7a,8,9,10,11,11a-octahydro-5H-dibenzo[a,c]cycloheptene-3-carboxylic acid (2-methyl-pyridin-3-yl)-amide

(7aSR,9SR,11aRS)-11a-ethyl-9-hydroxy-9-(3,3,3-trifluoro-propyl)-6,7,7a,8,9,10,11,11a-octahydro-5H-dibenzo[a,c]cycloheptene-3-carboxylic acid (2-methyl-pyridin-3-yl)-amide

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran; toluene at 20℃; for 0.0833333h;82%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

phthalic anhydride
85-44-9

phthalic anhydride

2-(2-methylpyridin-3-yl)isoindoline-1,3-dione

2-(2-methylpyridin-3-yl)isoindoline-1,3-dione

Conditions
ConditionsYield
With acetic acid at 100℃; Inert atmosphere;82%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

(4bRS,7RS,8aRS)-methyl 4b-ethyl-7-propyl-7-hydroxy-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate

(4bRS,7RS,8aRS)-methyl 4b-ethyl-7-propyl-7-hydroxy-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxylate

(4bRS,7RS,8aRS)-4b-ethyl-7-propyl-7-hydroxy-N-(2-methylpyridin-3-yl)-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxamide

(4bRS,7RS,8aRS)-4b-ethyl-7-propyl-7-hydroxy-N-(2-methylpyridin-3-yl)-4b,5,6,7,8,8a-hexahydrophenanthrene-2-carboxamide

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran; toluene at 0 - 20℃; for 1.5h; Inert atmosphere;74%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

Phenyl N-phenylphosphoramidochloridate
51766-21-3

Phenyl N-phenylphosphoramidochloridate

phenyl N-(2-methylpyridin-3-yl)-N'-phenylphosphorodiamidate

phenyl N-(2-methylpyridin-3-yl)-N'-phenylphosphorodiamidate

Conditions
ConditionsYield
With N,N'-dimethylpiperazine In tetrahydrofuran at 30 - 50℃; for 4h;74%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

C8H7ClINO

C8H7ClINO

1-(2-iodophenyl)-1-methyl-3-(2-methylpyridin-3-yl)urea

1-(2-iodophenyl)-1-methyl-3-(2-methylpyridin-3-yl)urea

Conditions
ConditionsYield
Stage #1: 2-methyl-3-pyridinamine With sodium hexamethyldisilazane In tetrahydrofuran at -78℃; for 0.5h;
Stage #2: C8H7ClINO In tetrahydrofuran at -78 - 20℃; for 2h;
71%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

N-(benzyloxycarbonyl)succinimide
75315-63-8

N-(benzyloxycarbonyl)succinimide

3-(N-benzyloxycarbonyl)-2-methylpyridine
177559-93-2

3-(N-benzyloxycarbonyl)-2-methylpyridine

Conditions
ConditionsYield
In N,N-dimethyl-formamide for 48h;68%
In N,N-dimethyl-formamide for 48h;68%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

5-bromo-2-methyl-thiazole-4-carboxylic acid (5-fluoro-pyridin-2-yl)-amide
899897-86-0

5-bromo-2-methyl-thiazole-4-carboxylic acid (5-fluoro-pyridin-2-yl)-amide

2-Methyl-5-(2-methyl-pyridin-3-ylamino)-thiazole-4-carboxylic acid (5-fluoro-pyridin-2-yl)-amide

2-Methyl-5-(2-methyl-pyridin-3-ylamino)-thiazole-4-carboxylic acid (5-fluoro-pyridin-2-yl)-amide

Conditions
ConditionsYield
With caesium carbonate; tris(dibenzylideneacetone)dipalladium(0) chloroform complex; 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene In 1,4-dioxane at 100 - 150℃; for 0.5h; Microwave irradiation;68%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

(4βS,7R,8αR)-methyl 4β-benzyl-7-(bis(benzyloxy)phosphoryloxy)-7-(trifluoromethyl)-4β,5,6,7,8,8α,9,10-octahydrophenanthrene-2-carboxylate
1044535-54-7

(4βS,7R,8αR)-methyl 4β-benzyl-7-(bis(benzyloxy)phosphoryloxy)-7-(trifluoromethyl)-4β,5,6,7,8,8α,9,10-octahydrophenanthrene-2-carboxylate

dibenzyl (2R,4αS,10αR)-4α-benzyl-7-((2-methylpyridin-3-yl)carbamoyl)-2-(trifluoromethyl)-1,2,3,4,4α,9,10,10α-octahydrophenanthren-2-ylphosphate
1044535-56-9

dibenzyl (2R,4αS,10αR)-4α-benzyl-7-((2-methylpyridin-3-yl)carbamoyl)-2-(trifluoromethyl)-1,2,3,4,4α,9,10,10α-octahydrophenanthren-2-ylphosphate

Conditions
ConditionsYield
With lithium hexamethyldisilazane In tetrahydrofuran at 0 - 10℃; for 0.5h; Product distribution / selectivity;68%
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

3-fluoro-2-methylpyridine

3-fluoro-2-methylpyridine

Conditions
ConditionsYield
With tetrafluoroboric acid; ethyl nitrite Balz-Schiemann reaction;66%
Stage #1: 2-methyl-3-pyridinamine With phosphoric acid In tert-butyl alcohol Balz-Schiemann Reaction; Inert atmosphere;
Stage #2: With tert.-butylnitrite; potassium phenyltrifluoborate In tert-butyl alcohol at 20 - 50℃; for 2.33333h; Balz-Schiemann Reaction; Inert atmosphere;
Stage #3: With 2,4-Dinitrofluorobenzene In dimethylsulfoxide-d6; tert-butyl alcohol at 20℃; Inert atmosphere;
35 %Spectr.
2-methyl-3-pyridinamine
3430-10-2

2-methyl-3-pyridinamine

acetic anhydride
108-24-7

acetic anhydride

1-(1H-pyrazolo[4,3-b]pyridin-1-yl)-ethan-1-one
52090-62-7

1-(1H-pyrazolo[4,3-b]pyridin-1-yl)-ethan-1-one

Conditions
ConditionsYield
Stage #1: 2-methyl-3-pyridinamine; acetic anhydride In chloroform at 0 - 20℃;
Stage #2: With potassium acetate; isopentyl nitrite In chloroform Reflux;
65%

3430-10-2Relevant articles and documents

Reduction of 2-amino-3- and -5-nitropyridine derivatives with hydrazine hydrate

Smolyar,Yutilov

, p. 115 - 118 (2009)

The reactions of 2-amino-3-nitropyridine and 2-amino-5-nitropyridine with hydrazine hydrate resulted in elimination of the amino group and reduction of the nitro group with formation of 3-aminopyridine. A probable reaction mechanism involves addition of hydrazine hydrate at the N-C2 bond, followed by elimination of ammonia and reduction of the nitro group to amino. 2-Amino-4-methyl-3-nitropyridine and 2-amino-5-methyl-3-nitropyridine reacted with hydrazine hydrate in a similar way.

Synthesis of some fluorine-containing pyridinealdoximes of potential use for the treatment of organophosphorus nerve-agent poisoning

Timperley, Christopher M.,Banks, R. Eric,Young, Ian M.,Haszeldine, Robert N.

, p. 541 - 547 (2011/09/15)

Fluoroheterocyclic aldoximes were screened as therapeutic agents for the treatment of anticholinesterase poisoning. 2-Fluoropyridine-3- and -6-aldoxime, and 3-fluoropyridine-2- and -4-aldoxime, were synthesised. Attempts to obtain 3,5,6-trifluoropyridine-2,4-bis(aldoxime) and -2-aldoxime, however, proved unsuccessful. Pentafluorobenzaldoxime was prepared by oximation of pentafluorobenzaldehyde. Acid dissociation constants (pKa) and second-order rate constants (kox-) of the fluorinated pyridinealdoximes towards sarin were measured. 2,3,5,6-Tetrafluoropyridine-4- aldoxime had the best profile: its kox- approached that of the therapeutic oxime P2S (310 vs. 120 l mol-1 min-1), but its higher pKa (9.1 vs. 7.8) fell short of the target figure of 8 required for reactivation of inhibited acetylcholinesterase in vivo. N-alkylation of the fluorinated pyridine-aldoximes may reduce their pK a nearer to 8 and enhance their therapeutic potential. Crown Copyright

PYRAZOLE COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME

-

Page/Page column 134, (2008/06/13)

The present invention provides a novel compound having an excellent JNK inhibitory effect. That is, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. Wherein R1 designates -(CO)h-(NRa)j-(CRb=CRc)k-Ar (wherein Ra, Rb and Rc each independently designate a hydrogen atom, a halogen atom, hydroxyl group, an optionally substituted C1-6 alkyl group or the like; Cy designates a 5- or 6-membered heteroaryl; and V each independently designate the formula -L-X-Y (wherein L designates a single bond, an optionally substituted C1-6 alkylene group or the like; X designates a single bond or the formula -A- (wherein A designates NR2, O, CO, S, SO or SO2) and so on; and Y designates a hydrogen atom, a halogen atom, nitro group or the like).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3430-10-2